![ESHMPN2024 Insights: Outstanding presentation by Lina Benajiba](https://oncodaily.com/pub/uploads/2024/04/ESH-Haematology-1280x720.jpeg)
ESHMPN2024 Insights: Outstanding presentation by Lina Benajiba
The European School of Haematology (ESH), shared on X (Twitter) insights from the 10th Translational Research Conference on Myeloproliferative Neoplasms (ESHMPN2024):
“Dr Lina Benajiba delivered an outstanding presentation revealing the transformation paths of MPNs, complemented by a captivating model.”
Lina Benajiba is a physician scientist, hematologist & clinical pharmacologist at the St. Louis Hospital (Hôpital Saint-Louis AP-HP), Assistant Professor at the INSERM Institute of Health and Medical Research, in Paris France.
Her research is focused on identification and targeting of extrinsic regulators of myeloid malignancies.
Lina Benajiba / leukemiarf.org
The 10th Translational Research Conference on Myeloproliferative Neoplasms (ESHMPN2024)
The 10th Translational Research Conference on Myeloproliferative Neoplasms (ESHMPN2024) is held in Mandelieu-La Napoule, France, from April 26 to April 28.
The conference is co-chaired by Jean-Jacques Kiladjian, Ross Levine, and Jyoti Nangalia.
The 10th Translational Research Conference on Myeloproliferative Neoplasms (ESHMPN2024)
The European School of Haematology (ESH), established in 1985, is a non-profit organization dedicated to fostering education and sharing advanced knowledge in hematology and associated fields across Europe.
ESH offers both in-person and online training opportunities, and its conferences showcase the latest scientific advancements and research in hematology.
OncoDaily is a leading global media platform in oncology, committed to being the voice of oncology.